Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Tech Gazette.
Press releases published on June 3, 2025
CancerVax Scientists Featured on Cytiva’s “Discovery Matters” Podcast Discussing Universal Cancer Vaccine Platform
GlobeNewswire
·
June 3, 2025
Lehi, June 03, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah – June 3rd, 2025 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment (UCT) platform that will use the body’s immune system to fight cancer, today announced that two of its lead …
Life360 Announces Pricing of Upsized Convertible Senior Notes Offering
GlobeNewswire
·
June 3, 2025
SAN FRANCISCO, June 03, 2025 (GLOBE NEWSWIRE) -- Life360, Inc. (“Life360” or the “Company”) (NASDAQ: LIF, ASX: 360), today announced the pricing of its offering of $275.0 million aggregate principal amount of 0.00% convertible senior notes due 2030 (the “ …
argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 3, 2025
June 3, 2025 Amsterdam, the Netherlands – argenx (Euronext …
Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
GlobeNewswire
·
June 3, 2025
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease Fourth orphan drug designation for rilzabrutinib in rare diseases Under regulatory review in the US, the EU, and China in immune thrombocytopenia Paris, June 3, 2025. The US …
Communiqué de presse : Le rilzabrutinib obtient la désignation de médicament orphelin aux États-Unis pour le traitement de la drépanocytose
GlobeNewswire
·
June 3, 2025
Le rilzabrutinib obtient la désignation de médicament orphelin aux États-Unis pour le traitement de la drépanocytose Quatrième désignation de médicament orphelin pour le rilzabrutinib dans les maladies rares En cours d’examen réglementaire aux États-Unis, …
Addex Convenes Annual General Meeting 2025
GlobeNewswire
·
June 3, 2025
Geneva, Switzerland, June 3, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that …
The Crisis of Care: Caily Confronts Caregiver Burnout with Launch of Comprehensive Digital Platform in Summer 2025
GlobeNewswire
·
June 3, 2025
Denver, CO, June 02, 2025 (GLOBE NEWSWIRE) -- As caregiver burnout reaches unprecedented levels across the United States, a new health tech startup, Caily, is stepping forward to address what experts are calling a growing public health emergency. The …